NL-OMON50825已完成不适用
Early clinical feasibility study of a new voice prosthesis: the Provox Vega HP - Vega HP study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Laryngectomized patients using either the Provox Vega 22.5 or the Provox
- •ActiValve Light voice prosthesis, with a length of 4, 6, 8, or 10 mm
- •18 years and older
排除标准
- •Current tracheoesophageal puncture problems such as enlarged puncture or
- •Active recurrent or metastatic disease (medical deterioration)
- •The use of ActiValve Strong/XtraStrong or XtraSeal
- •Unable to understand the Patient Information and/or unable to give Informed
研究者
相似试验
已完成
不适用
Early clinical feasibility study of a new voice prosthesis: the Provox Vega HP'total laryngectomy' 'voice rehabilitation'10019190NL-OMON38672Atos Medical AB16
已完成
不适用
Clinical Feasibility of a New Voice ProsthesisLaryngectomyNCT05079386Atos Medical AB17
已完成
不适用
An early clinical feasibility study of a new prosthesis: the NewBreez® Intralaryngeal device; a possible solution for severe aspiration in head and neck cancer patientsaspirationDysfunctional larynxswallowing impairment10027656NL-OMON42228Antoni van Leeuwenhoek Ziekenhuis5
终止
不适用
Long-term Clinical Feasibility of the New Indwelling Provox Vega 20 Voice ProsthesisTotal LaryngectomyNCT00661570Atos Medical AB26
已完成
2 期
Phase 2 clinical feasibility study of a new Speaking Valve with a heat- and moisture exchanger (TW) for tracheotomized patients.tracheostomyairway openingTracheotomy10046304NL-OMON38448Atos Medical AB20